Search results
AstraZeneca's Combination Inhaler Shines In Phase 3 Asthma Trial
Benzinga via Yahoo Finance· 2 years agoAstraZeneca Plc (NASDAQ: AZN) posted full results from the positive MANDALA Phase 3 trial of PT027,...
FDA Approves the First Oral Treatment for Eosinophilic Esophagitis
Verywell Health via Yahoo News· 2 months agoVerywell / Julie Bang Fact checked by Nick Blackmer Key Takeaways The FDA approved Takeda’s Eohilia,...
AstraZeneca's New Asthma Treatment for Adults Gets Green Light from FDA
Benzinga via Yahoo Finance· 1 year agoThe FDA approved AstraZeneca Plc's (NASDAQ: AZN) Airsupra, formerly PT027, as the first and only...
Could AstraZeneca's Asthma Drug Candidate Generate Billions?
Motley Fool· 1 year agoLast month, British drugmaker AstraZeneca (NASDAQ: AZN) received good news from the U.S. Food and...
These Inhalers No Longer Cost More Than $35 Per Month
Verywell Health via Yahoo News· 1 month agoGrace Cary / Getty Images Fact checked by Nick Blackmer Key Takeaways Three major pharmaceutical...
FDA Adcomm Backs AstraZeneca's 2-In-1 Asthma Inhaler, Only For Adults Being Less Sure For...
Benzinga via Yahoo Finance· 1 year agoThe FDA's Pulmonary-Allergy Drugs Advisory Committee has voted 16 to 1 that the data support a...
Viatris (VTRS) Wins in Court Against AstraZeneca's Symbicort
Zacks via Yahoo Finance· 1 year agoViatris (VTRS) and its partner win a court decision that invalidates branded drug Symbicort's patent...
Calliditas Plans To File For Complete FDA Approval For Rare Kidney Disease Drug After Positive Phase...
Benzinga via Yahoo Finance· 1 year agoCalliditas Therapeutics AB (NASDAQ: CALT) announced topline results from the Phase 3 clinical trial...
Calliditas' Kinpeygo Receives CHMP Backing For Kidney Disease
Benzinga via Yahoo Finance· 2 years agoThe European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a...
Spring allergy season is off to an even earlier start this year
Popular Science via Yahoo News· 1 month agoSpring allergy season is beginning about 20 days earlier in North America. After a particularly mild...